Evaluation of Transdermal Nicotine Replacement Therapy (NRT) Activity Through Metabolic Induction
Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
Evaluation to determine if auto-induction can be used as a surrogate measure of nicotine
receptor up-regulation through an observational study using nicotine replacement therapy for
two weeks and no intervention for two weeks.
Phase:
Phase 1
Details
Lead Sponsor:
The Queen Elizabeth Hospital
Collaborators:
Basil Hetzel Institute for Translational Research Clinical Practice Unit Therapeutics Research Centre University of Adelaide University of South Australia